We are live on ! Find out more
CSBR icon

Champions Oncology
CSBR

35 hedge funds and large institutions have $64.1M invested in Champions Oncology in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 17 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

2.92% less ownership

Funds ownership: 49.71% → 46.78% (-2.9%)

6% less capital invested

Capital invested by funds: $68.5M → $64.1M (-$4.34M)

8% less funds holding

Funds holding: 38 → 35 (-3)

53% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 17

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Holders
35
Holders Change
-3
Holders Change %
-7.89%
% of All Funds
0.61%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
2
Increased
8
Reduced
17
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MAG
Millrace Asset Group
Pennsylvania
+$444K
2
BlackRock
BlackRock
New York
+$156K
3
ACM
ACT Capital Management
Pennsylvania
+$86.5K
4
HighTower Advisors
HighTower Advisors
Illinois
+$71.6K
5
Federated Hermes
Federated Hermes
Pennsylvania
+$60K

Top Sellers

Rank Fund Capital Flow
1
RC
Roubaix Capital
Colorado
-$3.61M
2
Millennium Management
Millennium Management
New York
-$284K
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$214K
4
OMC
Overbrook Management Corp
New York
-$137K
5
Morgan Stanley
Morgan Stanley
New York
-$131K
Name Holding Trade Value Shares
Change 		Change in
Stake
GC
26
Globeflex Capital
California
$87K – – –
Morgan Stanley
27
Morgan Stanley
New York
$70K -$131K -12,913 -65%
Federated Hermes
28
Federated Hermes
Pennsylvania
$59K +$60K +5,894 New
Barclays
29
Barclays
United Kingdom
$8K -$285 -28 -3%
TCWM
30
Total Clarity Wealth Management
Illinois
$7K +$7.25K +713 New
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
$1K -$12.5K -1,229 -91%
TRCT
32
Tower Research Capital (TRC)
New York
$1K -$5.68K -558 -83%
BNP Paribas Financial Markets
33
BNP Paribas Financial Markets
France
$459 -$14.5K -1,429 -97%
RC
34
Roubaix Capital
Colorado
– -$3.61M -351,507 Closed
JP Morgan Chase
35
JP Morgan Chase
New York
– -$44.4K -4,368 -100%
Bank of America
36
Bank of America
North Carolina
– -$15K -1,430 Closed
PAM
37
Panagora Asset Management
Massachusetts
– -$3K -278 Closed
UBS Group
38
UBS Group
Switzerland
– -$1K -76 Closed
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
– -$1K -62 Closed
Wells Fargo
40
Wells Fargo
California
– +$41 +4 +11%
1
2

CSBR Hedge Fund Activity: Q3 2021 in Review

35 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q3 2021, worth a combined $64.1M — down 6.3% from $68.5M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of CSBR and 2 opened new positions — a net loss of 3 holders — while 17 trimmed existing stakes and 8 added.

The largest buyer was Millrace Asset Group, adding an estimated $444K. The largest seller was Roubaix Capital, exiting entirely with an estimated $3.61M sold.

  • 35 institutional investors held Champions Oncology (CSBR) as of Q3 2021, down from 38 in Q2 2021.
  • Funds reported $64.1M of Champions Oncology stock for Q3 2021, down 6.3% quarter-over-quarter.
  • 2 funds opened new Champions Oncology positions in Q3 2021 and 5 closed out, a net change of -3 holders.
  • The largest Champions Oncology buyer in Q3 2021 was Millrace Asset Group, an estimated $444K added.
  • The largest Champions Oncology seller in Q3 2021 was Roubaix Capital, an estimated $3.61M sold.

Based on aggregated 13F filings for Q3 2021.